Precision Medicine for Cholesterol Treatment
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 21 of these applications claim priority to application 14/331,730, filed Jul 15, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,914,769 | Precision Medicine for Cholesterol Treatment In force · High confidence | Kymab Limited | In force | High confidence | ||
| US 11,555,066 | Precision Medicine for Cholesterol Treatment In force · High confidence | Kymab Limited | In force | High confidence | ||
| US 8,945,560 | Method of Treating Rheumatoid Arthritis Using Antibody to IL6R In force · High confidence | Kymab Limited | In force | High confidence | ||
| US 8,980,273 | Method of Treating Atopic Dermatitis or Asthma Using Antibody to IL4RA In force · High confidence | Kymab Limited | In force | High confidence | ||
| US 8,986,691 | Method of Treating Atopic Dermatitis or Asthma Using Antibody to IL4RA In force · High confidence | Kymab Limited | In force | High confidence | ||
| US 8,986,694 | Targeting Human NAV1.7 Variants for Treatment of Pain In force · High confidence | Kymab Limited | In force | High confidence | ||
| US 8,992,927 | Targeting Human NAV1.7 Variants for Treatment of Pain In force · High confidence | Kymab Limited | In force | High confidence | ||
| US 9,017,678 | Method of Treating Rheumatoid Arthritis Using Antibody to IL6R In force · High confidence | Kymab Limited | In force | High confidence | ||
| US 9,045,545 | Precision Medicine by Targeting PD-L1 Variants for Treatment of Cancer In force · High confidence | Kymab Limited | In force | High confidence | ||
| US 9,062,105 | Precision Medicine by Targeting VEGF-A Variants for Treatment of Retinopathy In force · High confidence | Kymab Limited | In force | High confidence | ||
| 15 more patents in this group · Pro | ||||||
10 of 25 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 25.
22 of these are in force and held by Kymab Limited.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.